Advanced search
Publication Cover
Journal of Asthma Volume 61, 2024 - Issue 6
Submit an article Journal homepage
1,143
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Exacerbations, treatment patterns, utilization, and costs before and after initiating of benralizumab for the treatment of severe eosinophilic asthma

Joseph L. Smitha Carelon Research, Wilmington, DE, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0288-5538View further author information
, PhD, MPHORCID Icon,
Yen Chungb AstraZeneca Pharmaceuticals, Wilmington, DE, USAView further author information
, PharmD,
John Barrona Carelon Research, Wilmington, DE, USAView further author information
, PharmD,
Theodore Barlowsb AstraZeneca Pharmaceuticals, Wilmington, DE, USAView further author information
, PharmD,
Bal Nepala Carelon Research, Wilmington, DE, USAView further author information
, PhD, MPH &
Donna Carstensb AstraZeneca Pharmaceuticals, Wilmington, DE, USAView further author information
, MD
Pages 520-531 | Received 26 Sep 2023, Accepted 25 Nov 2023, Published online: 08 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.